BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2008
View Archived Issues
New therapeutic approach against toxoplasmosis reported
Read More
MicroRNA mimics suppress Bcr-Abl expression in vitro and in vivo
Read More
Phase II trial of Hsp90 inhibitor alvespimycin begins in HER2+ metastatic breast cancer
Read More
Data support therapeutic role for buprenorphine in neuropathic pain
Read More
Allon initiates phase I clinical trial of AL-108 and AL-208
Read More
Three Rivers acquires hepatitis C drug Infergen from Valeant
Read More
Vasopressin V2 receptor agonists prepared and tested at Kissei
Read More
Roche responds to the results of the IDEAL hepatitis C trial reported
Read More
Upstream enters agreement with MSU for drug candidates for tropical parasitic diseases
Read More
FDA grants approval to DAKO to market the TOP2A FISH pharmDx breast-cancer test
Read More
Gabriel Sciences receives grant from NIH for development of lead antidepressant compound
Read More
Alfacell licenses U.S. commercial rights to Onconase to Strativa Pharmaceuticals
Read More
Taranabant induces weight loss in obese subjects
Read More
Novartis Pharma and Mitsubishi Tanabe revise agreement for Lochol for hypercholesteremia
Read More
Genzyme enters license agreement with Moffitt Cancer Center for lung cancer diagnostic
Read More
Tolerx receives payment from Genentech following phase Ib clinical study of TRX-1
Read More
Anthera reports positive preliminary results from phase IIb clinical trial of A-002
Read More
Celsion to proceed with phase II pivotal breast cancer trial
Read More
Protox Therapeutics commences phase IIa PRX-302 trial in prostate cancer
Read More
Summit's lead drug candidate, SMT-D001, enters phase II clinical trials
Read More
Recent patents describe novel analgesic agents
Read More
Remicade label enhancement receives E.U. approval in Crohn's disease
Read More
E.U. marketing authorization granted for GSK's Avamys for allergic rhinitis therapy
Read More
E.C. grants Remicade label enhancement for ankylosing spondylitis and psoriatic arthritis
Read More
New oncolytic drugs described in recent patents
Read More